Increased glucocorticoid activity in men with cardiovascular risk factors

Hypertension

Volumn 31, Issue 4, 1998, Pages 891-895

  Walker, Brian R ^a   Phillips, David I W ^c   Noon, Joseph P ^a   Panarelli, Maurizio ^a   Andrew, Ruth ^a   Edwards, Hugh V ^b   Holton, David W ^b   Seckl, Jonathan R ^a   Webb, David J ^a   Watt, Graham C M ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Ladywell Medical Centre   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Adrenal cortex hormones; Blood pressure; Blood vessels; Insulin; Receptors, corticosteroid

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; CORTICOSTEROID RECEPTOR; CORTISONE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; INSULIN; LIGAND;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG RECEPTOR BINDING; HORMONE ACTION; HUMAN; HUMAN CELL; HYDROCORTISONE RELEASE; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 0031899323     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.4.891     Document Type: Article

References (37)

1. Reaven GM, Hoffman BB. A role for insulin in the etiology and course of hypertension. Lancet. 1987;2:435-436.
2. Walker BR, Stewart PM, Shackleton CHL, Padfield PL, Edwards CRW. Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension. Clin Endocrinol (Oxf). 1993;39:221-227.
3. Soro A, Ingram MC, Tonolo G, Glorioso N, Fraser R. Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in patients with untreated essential hypertension. Hypertension. 1995;25:67-70.
4. Walker BR, Best R, Shackleton CHL, Padfield PL, Edwards CRW. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension. 1996;27:190-196.
5. Stewart PM, Whorwood CB, Valentino R, Burt D, Sheppard MC, Edwards CRW. 11-Beta-hydroxysteroid dehydrogenase activity and gene expression in the hypertensive Bianchi-Milan rat. J Hypertens. 1993;11: 349-354.
6. Suzuki H, Zweifach BW, Schmid PG. Dependence of elevated mesenteric arteriolar tone on glucocorticoids in spontaneously hypertensive rats. Int J Microcirc Clin Exp. 1995;15:309-315.
7. Watt GCM, Harrap SB, Foy CJW, Holton DW, Edwards HV, Davidson HR, Connor JM, Lever AF, Fraser R. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four corners approach to the identification of genetic determinants of blood pressure. J Hypertens. 1992;10:473-482.
8. Kenyon CJ, Panarelli M, Holloway CD, Dunlop D, Morton JJ, Connell JMC, Fraser R. The role of glucocorticoid activity in the inheritance of hypertension: studies in the rat. J Steroid Biochem Mol Biol. 1993;45:7-11.
9. Weaver JU, Hitman GA, Kopelman PG. An association between a BclI restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women. J Mol Endocrinol. 1992; 9:295-300.
10. Phillips DIW, Barker DJP, Hales CN, Hirst S, Osmond C. Thinness at birth and insulin resistance in adult life. Diabetologia. 1994;37:150-154.
11. Harrap SB, Davidson R, Connor M, Soubrier F, Corvol P, Fraser R, Foy CJW, Watt GCM. The angiotensin 1 converting enzyme gene and predisposition to high blood pressure. Hypertension. 1993;21:455-460.
12. Harrap SB, Samani NJ, Lodwick D, Connor JM, Fraser R, Davies DL, Lever AF, Foy CJW, Watt GCM. The SA gene: predisposition to hypertension and renal function in man. Clin Sci. 1995;88:665-670.
13. Harrap SB, Dominiczak AF, Fraser R, Lever AF, Morton JJ, Foy CJ, Watt GCM. Plasma angiotensin II predisposition to hypertension and left ventricular size in young adults. Circulation. 1996;93:1148-1154.
14. Harrap SB, Fraser R, Inglis GC, Lever AF, Beastall GH, Dominiczak MH, Foy CJW, Watt GCM. Abnormal epinephrine release in young adults with high personal and parental blood pressures. Circulation. 1997;96:556-561.
15. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GCM. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest. 1997;99:1873-1879.
16. Matthews DR, Hosker IP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985;28:412-419.
17. McKenzie AW, Stoughton RB. Method for comparing percutaneous absorption of steroids. Arch Dermatol. 1962;86:608-610.
18. Teelucksingh S, Mackie ADR, Burt D, McIntyre MA, Brett L, Edwards CRW. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet. 1990;335:1060-1063.
19. Brown PH, Teelucksingh S, Matusiewicz SP, Greening AP, Crompton GK, Edwards CRW. Cutaneous vasoconstrictor response to glucocorticoids in asthma. Lancet. 1991;337:576-580.
20. Walker BR, Connacher AA, Webb DJ, Edwards CRW. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. Clin Sci. 1992;83:171-178.
21. Noon JP, Evans CE, Haynes WG, Webb DJ, Walker BR. A comparison of techniques to assess skin blanching following topical application of glucocorticoids. Br J Dermatol. 1996;134:837-842.
22. Best R, Walker BR, Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo. Clin Endocrinol (Oxf). 1997;47: 231-236.
23. Panarelli M, Holloway CD, Mulatero P, Fraser R, Kenyon CJ. Inhibition of lysozyme synthesis by dexamethasone in human mononuclear leukocytes: an index of glucocorticoid sensitivity. J Clin Endocrinol Metab. 1994;78:872-877.
24. Zumoff B, Fukushima DK, Hellman L. Intercomparison of four methods for measuring cortisol production. J Clin Endocrinol Metab. 1974;38:169-175.
25. Marks R, Barlow JW, Funder JW. Steroid-induced vasoconstriction: glucocorticoid antagonist studies. J Clin Endocrinol Metab. 1982;54: 1075-1077.
26. Gaillard RC, Poffet D, Riondel AM, Saurat J-H. RU486 inhibits peripheral effects of glucocorticoids in humans. J Clin Endocrinol Metab. 1985;61:1009-1011.
27. Dallman MF, Strack AM, Akana SF, Bradbury MJ, Hanson ES, Scribner KA, Smith M. Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol. 1993;14:303-347.
28. Carmichael J, Paterson IC, Diaz P, Crompton GK, Kay AB, Grant IWB. Corticosteroid resistance in chronic asthma. Br Med J. 1981;282: 1419-1422.
29. Strahle U, Schmidt A, Kelsey G, Stewart AF, Cole TJ, Schmid W, Schutz G. At least three promoters direct expression of the mouse glucocorticoid receptor gene. Proc Natl Acad Sci U S A. 1992;89:6731-6735.
30. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and ageing: the glucocorticoid cascade hypothesis. Endocr Rev. 1986;7: 284-301.
31. Groote Veldman R, Meinders AE. On the mechanism of alcohol-induced pseudo-Cushing's syndrome. Endocr Rev. 1996;17:262-267.
32. Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, Labate AMM, Barabara L. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab. 1993;77:341-346.
33. Marin P, Darin M, Amemiya T, Andersson B, Jern S, Bjorntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism. 1992;41:882-886.
34. Aromaa A, Raitasalo R, Reunanen A, Impivaara O, Heliovaara M, Knekt P, Lehtinen V, Joukamaa M, Maatela J. Depression and cardiovascular diseases. Acta Pyschiatr Scand Suppl. 1994;89:77-82.
35. Bjorntorp P. Visceral fat accumulation: the missing link between psychosocial factors and cardiovascular disease? J Intern Med. 1991;230: 195-201.
36. Hautanen A, Adlercreutz H. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J Intern Med. 1993;234:461-469.
37. Shakhov Y, Petrichenko I, Fuki I. Reduced sensitivity of cultured skin fibroblasts from familial hypercholesterolemic patients to glucocorticoids. Life Sci. 1993;53:1617-1624.